Apocynin treatment has been shown to reduce ROS generation in activated microglia/macrophages after stroke [213,219], and we recently presented a novel finding that apocynin treatment reduces Nox2 expression after stroke without affecting inflammatory cell numbers [217]. This evidence concerns the gene CYBB and stroke disorder.